11,009 Shares in CVS Health Corporation (NYSE:CVS) Purchased by Ritholtz Wealth Management

Ritholtz Wealth Management acquired a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,009 shares of the pharmacy operator's stock, valued at approximately $746,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CVS. Blodgett Wealth Advisors LLC purchased a new stake in shares of CVS Health during the 1st quarter valued at approximately $201,000. Dynamic Advisor Solutions LLC raised its holdings in CVS Health by 92.7% during the 1st quarter. Dynamic Advisor Solutions LLC now owns 37,013 shares of the pharmacy operator's stock valued at $2,508,000 after acquiring an additional 17,807 shares during the period. Missouri Trust & Investment Co boosted its holdings in shares of CVS Health by 11.1% in the first quarter. Missouri Trust & Investment Co now owns 24,379 shares of the pharmacy operator's stock worth $1,652,000 after acquiring an additional 2,435 shares during the period. Everpar Advisors LLC purchased a new position in shares of CVS Health in the first quarter valued at $371,000. Finally, Opal Wealth Advisors LLC bought a new stake in shares of CVS Health during the 1st quarter valued at $115,000. Institutional investors own 80.66% of the company's stock.

Insider Transactions at CVS Health

In related news, Director Guy P. Sansone purchased 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.22% of the company's stock.

CVS Health Stock Down 0.3%

Shares of CVS opened at $66.91 on Thursday. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $72.51. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The stock has a 50 day simple moving average of $65.02 and a two-hundred day simple moving average of $60.30. The firm has a market cap of $84.64 billion, a P/E ratio of 15.97, a P/E/G ratio of 0.96 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The firm's revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 EPS. On average, analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CVS. Cowen reaffirmed a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Robert W. Baird upped their target price on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Barclays set a $79.00 price target on shares of CVS Health and gave the company an "overweight" rating in a report on Monday, June 2nd. Finally, Mizuho upped their price target on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Two analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $74.75.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.